Find Grants for Large Businesses
Find out if you qualify for verified grants for Large Businesses . Discover your eligibility and key funding details for Large Businesses from major foundations and government agencies.
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
Deadline: October 16, 2026
Opportunity Number: PAR-25-077
Agency: National Institutes of Health
Open Date: November 1, 2024
Close Date: October 16, 2026
Status: Posted
CFDA Numbers: 93.853, 93.855
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-143
Agency: National Institutes of Health
Open Date: October 31, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.279, 93.242, 93.273, 93.989, 93.307, 93.172, 93.866, 93.399, 93.846, 93.361, 93.173, 93.121, 93.113, 93.855, 93.865, 93.213, 93.853, 93.310
Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
Deadline: January 7, 2028
Opportunity Number: PAR-25-207
Agency: National Institutes of Health
Open Date: October 31, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
Deadline: June 2, 2027
Opportunity Number: PAR-25-210
Agency: National Institutes of Health
Open Date: October 31, 2024
Close Date: June 2, 2027
Status: Posted
CFDA Numbers: 93.866, 93.313, 93.393, 93.213, 93.121
Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)
Deadline: June 2, 2027
Opportunity Number: PAR-25-211
Agency: National Institutes of Health
Open Date: October 31, 2024
Close Date: June 2, 2027
Status: Posted
CFDA Numbers: 93.393, 93.121, 93.213, 93.313, 93.866
Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
Deadline: January 7, 2028
Opportunity Number: PAR-25-206
Agency: National Institutes of Health
Open Date: October 31, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-233
Agency: National Institutes of Health
Open Date: October 30, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.399, 93.242, 93.121, 93.279, 93.310, 93.113, 93.853, 93.172, 93.989, 93.273, 93.865, 93.866
Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)
Deadline: July 14, 2026
Opportunity Number: PAR-24-313
Agency: National Institutes of Health
Open Date: October 30, 2024
Close Date: July 14, 2026
Status: Posted
CFDA Numbers: 93.213
Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-185
Agency: National Institutes of Health
Open Date: October 30, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.865, 93.121, 93.351
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
Deadline: July 14, 2026
Opportunity Number: PAR-24-312
Agency: National Institutes of Health
Open Date: October 29, 2024
Close Date: July 14, 2026
Status: Posted
CFDA Numbers: 93.213
Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
Deadline: April 15, 2027
Opportunity Number: PAR-25-131
Agency: National Institutes of Health
Open Date: October 29, 2024
Close Date: April 15, 2027
Status: Posted
CFDA Numbers: 93.879
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-144
Agency: National Institutes of Health
Open Date: October 29, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.279, 93.242, 93.273, 93.866, 93.847, 93.307, 93.172, 93.846, 93.399, 93.853, 93.837, 93.361, 93.867, 93.855, 93.213, 93.121, 93.865, 93.113, 93.839, 93.840, 93.233, 93.838, 93.310
Translational Neural Devices (R61/R33 - Clinical Trial Optional)
Deadline: January 28, 2027
Opportunity Number: PAR-25-053
Agency: National Institutes of Health
Open Date: October 29, 2024
Close Date: January 28, 2027
Status: Posted
CFDA Numbers: 93.853
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-024
Agency: National Institutes of Health
Open Date: October 28, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.853, 93.866
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)
Deadline: November 16, 2027
Opportunity Number: PAR-25-122
Agency: National Institutes of Health
Open Date: October 28, 2024
Close Date: November 16, 2027
Status: Posted
CFDA Numbers: 93.121, 93.853, 93.173, 93.350, 93.855, 93.242
BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)
Deadline: June 15, 2027
Opportunity Number: RFA-MH-26-140
Agency: National Institutes of Health
Open Date: October 23, 2024
Close Date: June 15, 2027
Status: Posted
CFDA Numbers: 93.286, 93.173, 93.867, 93.213, 93.273, 93.853, 93.866, 93.242, 93.865
NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Deadline: January 6, 2028
Opportunity Number: PAR-25-057
Agency: National Institutes of Health
Open Date: October 23, 2024
Close Date: January 6, 2028
Status: Posted
CFDA Numbers: 93.121
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)
Deadline: October 20, 2027
Opportunity Number: PAR-25-060
Agency: National Institutes of Health
Open Date: October 22, 2024
Close Date: October 20, 2027
Status: Posted
CFDA Numbers: 93.853
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
Deadline: October 20, 2027
Opportunity Number: PAR-25-059
Agency: National Institutes of Health
Open Date: October 22, 2024
Close Date: October 20, 2027
Status: Posted
CFDA Numbers: 93.853
NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
Deadline: October 15, 2027
Opportunity Number: PAR-25-120
Agency: National Institutes of Health
Open Date: October 18, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.173
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
Deadline: October 14, 2026
Opportunity Number: PAR-25-074
Agency: National Institutes of Health
Open Date: October 15, 2024
Close Date: October 14, 2026
Status: Posted
CFDA Numbers: 93.394
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
Deadline: October 14, 2026
Opportunity Number: PAR-25-075
Agency: National Institutes of Health
Open Date: October 15, 2024
Close Date: October 14, 2026
Status: Posted
CFDA Numbers: 93.394
Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
Deadline: July 14, 2026
Opportunity Number: PAR-24-276
Agency: National Institutes of Health
Open Date: October 15, 2024
Close Date: July 14, 2026
Status: Posted
CFDA Numbers: 93.213
Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)
Deadline: January 6, 2028
Opportunity Number: PAR-25-062
Agency: National Institutes of Health
Open Date: October 10, 2024
Close Date: January 6, 2028
Status: Posted
CFDA Numbers: 93.121
Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
Deadline: January 7, 2027
Opportunity Number: PAR-25-098
Agency: National Institutes of Health
Open Date: October 10, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.399, 93.307, 93.121, 93.313
